Navigation Links
PhastSystem Separation-Control and Development Units 220 VAC

ProductsPhastSystem Separation-Control and Development Units 220 VAC
Company GE Healthcare, formerly Amersham Biosciences
Item PhastSystem Separation-Control and Development Units 220 VAC
Features 
  • Automatically separate and stain proteins under controlled power and temperature conditions.
  • Program and store nine separation protocols of nine steps each, and nine staining protocols of 20 steps each.
  • Regulate gel temperature through Peltier-controlled support bed.
  • Assure reproducibility with quality-tested precast gels, buffer strips, and staining kits.
Description PhastSystem™ consists of a Separation-Control unit for system control and electrophoresis, and a Development Unit for gel staining. The optional PhastTransfer Kit quickly converts the system into a semi-dry blotting unit. Electrophoresis is performed on a thermostatic plate capable of maintaining temperatures accurately from 0 to +70 C. Multi-step programming capability allows gels to be prerun, loaded, and run automatically. Controlled parameters include temperature, voltage, current, power, and volt-hours.
Info 

Related medicine products :

1. PhastSystem Separation-Control and Development Units 120 VAC
2. Siemens Webcast: Legislative Developments Impacting Cardiology Services Reimbursement
3. Assay Development
4. Terry-Schanzlin Astigmatome - 6.0mm Disposable Single Blade Units
5. Terry-Schanzlin Astigmatome - 8.0mm Disposable Single Blade Units
6. Terry-Schanzlin Astigmatome - 10.0mm Disposable Single Blade Units
7. Terry-Schanzlin Astigmatome -10.0mm Disposable Double Blade Units
8. Terry-Schanzlin Astigmatome - 6.0mm Disposable Double Blade Units
9. Terry-Schanzlin Astigmatome - 8.0mm Disposable Double Blade Units
10. ENDO GIA ROTICULATOR™ (Single Use Loading Units (SULUs) with Titanium Staples)
11. MULTIFIRE ENDO GIA™ 30 (Single Use Loading Units (SULUs) with Titanium Staples)
Inquire...
Inquire...
... Agarose is a premium agarose used for ... This agarose produces clear sharp bands, with ... lot of UltraClean Forensic Agarose is tested ... activity, RNase activity and DNA contamination. ...
Inquire...
Medicine Products:
(Date:12/9/2016)... ... 2016 , ... The Pennsylvania Athletic Trainers’ Society (PATS) aired ... of 2016. The program was made possible by a Pennsylvania Department of Health ... and Human Services Administration. The broadcast, Use Your Head: Properly Managing Sport ...
(Date:12/8/2016)... ... 2016 , ... The Florida Hospital Tampa Wound Healing Institute ... (UHMS), the leading authority in hyperbaric medicine. This accreditation identifies the Institute as ... facilities have earned this distinction. This is the second time the Florida Hospital ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported ... , “This was our first franchise-wide Quack Gives Back initiative, and ...
(Date:12/8/2016)... and JENNERSVILLE, Pa. (PRWEB) , ... December 08, ... ... that Penn Medicine Southern Chester County, a Property owned by an affiliate of ... million, 72,000 square foot Penn Medicine Southern Chester County ambulatory care center (ACC) ...
(Date:12/8/2016)... ... ... CURE Media Group, the nation’s leading digital and print media enterprise focused ... in efforts to combat lung cancer, announced CURE Media Group President Michael J. Hennessy, ... is honored to team up with Upstage Lung Cancer in order to make major ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  Pennsylvania Physician ... of Drug and Alcohol Programs Gary Tennis ... insomnia medications, known as benzodiazepines, developed with the ... "Benzodiazepines are medications that are frequently prescribed for ... they are used with opioid pain medications, benzodiazepines ...
(Date:12/8/2016)... 2016  A new study by a pair of ... opioid therapy to treat chronic pain is not only ... harmful consequences, including death. Palliative care physicians ... Mehta , M.D., authored the study which provides a ... The study was published in the December 2016 edition ...
(Date:12/8/2016)... , Dec. 8, 2016  EIP Pharma, LLC ... obtained proof-of-mechanism for neflamapimod (previously code named VX-745), ... 2a clinical trials that demonstrated significant Alzheimer,s disease ... (12-week treatment) and Study 303 (6-week treatment) are ... in Alzheimer,s Disease (CTAD) scientific conference in ...
Breaking Medicine Technology: